Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S. [PDF]
Crittenden D +4 more
europepmc +1 more source
Comparison of generic drug prices in Korea and eight high-income countries across four therapeutic classes. [PDF]
Park C, Kim DS, Song I.
europepmc +1 more source
A sex-sensitive LC-MS/MS method with isotopic internal standard for prazosin bioequivalence: bridging precision medicine and generic drug policy in China. [PDF]
Chen H, Guo J, Zhu Z, Huang X, Guo J.
europepmc +1 more source
Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States.
Walsh BS +3 more
europepmc +1 more source
A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage forms. [PDF]
Hsieh NH +8 more
europepmc +1 more source
Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus. [PDF]
Karakitsios E +5 more
europepmc +1 more source
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea. [PDF]
Son KB.
europepmc +1 more source
Association of California's Prescription Drug Coupon Ban With Generic Drug Use.
Rome BN, Gagne JJ, Kesselheim AS.
europepmc +1 more source
Expected Next-Generation Drugs [PDF]
openaire +3 more sources
A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy. [PDF]
Yang J +12 more
europepmc +1 more source

